scholarly journals Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

2021 ◽  
Author(s):  
Mariaelena Pierobon ◽  
Nicholas J. Robert ◽  
Donald W. Northfelt ◽  
Mohammad Jahanzeb ◽  
Shukmei Wong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Molecular Profiling ◽  
Treatment Selection ◽  
Phase Ii Clinical Trial ◽  
Efficacious Treatment ◽  
Prospective Phase

Final Results of a Phase II Clinical Trial of Weekly Docetaxel in Combination with Capecitabine in Anthracycline-Pretreated Metastatic Breast Cancer

2004 ◽  
Vol 5 (4) ◽  
pp. 287-292 ◽  
Author(s):  
John R. Mackey ◽  
Katia S. Tonkin ◽  
Sheryl L. Koski ◽  
Andrew G. Scarfe ◽  
Michael G.B. Smylie ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Phase Ii Clinical Trial ◽  
Weekly Docetaxel

Preliminary Results or a Phase II Clinical Trial Utilising Tru-Scint® AD™ in Primary and Metastatic Breast Cancer

1994 ◽  
Vol 19 (10) ◽  
pp. 932
Author(s):  
A. J.B. McEwan ◽  
G. D. MacLean ◽  
L. Golberg ◽  
K. Golberg ◽  
G. R. Boniface ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Phase Ii Clinical Trial ◽  
Preliminary Results

Phase II Clinical Trial of Titanocene Dichloride in Patients with Metastatic Breast Cancer

2000 ◽  
Vol 23 (1) ◽  
pp. 60-62 ◽  
Author(s):  
N. Kröger ◽  
U.R. Kleeberg ◽  
K. Mross ◽  
L Edler ◽  
D.K. Hossfeld
Keyword(s):  
Breast Cancer ◽  
Clinical Trial ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Metastatic Breast ◽  
Phase Ii Clinical Trial ◽  
Titanocene Dichloride
Sign in / Sign up

Export Citation Format

Share Document